Trial
NCT00661336
A Phase I Trial of Normothermic Isolated Limb Infusion (ILI) With Melphalan Plus Buthionine Sulfoximine (BSO) in Patients With Locally Advanced Malignant Melanoma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Duke University
Collaborators
National Cancer Institute (NCI)
Condition
Melanoma (Skin)
Intervention
buthionine sulfoximine
Why stopped
The study was withdrawn due to lack of patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-13